Ma, Y.; Ling, S.; Li, Y.; Hu, M.; Kong, B.; Huang, P.; Liu, H.
Loss of Heterozygosity for KrasG12D Promotes Malignant Phenotype of Pancreatic Ductal Adenocarcinoma by Activating HIF-2α-c-Myc-Regulated Glutamine Metabolism. Int. J. Mol. Sci. 2022, 23, 6697.
https://doi.org/10.3390/ijms23126697
AMA Style
Ma Y, Ling S, Li Y, Hu M, Kong B, Huang P, Liu H.
Loss of Heterozygosity for KrasG12D Promotes Malignant Phenotype of Pancreatic Ductal Adenocarcinoma by Activating HIF-2α-c-Myc-Regulated Glutamine Metabolism. International Journal of Molecular Sciences. 2022; 23(12):6697.
https://doi.org/10.3390/ijms23126697
Chicago/Turabian Style
Ma, Yu, Sunkai Ling, Yuan Li, Mingyue Hu, Bo Kong, Peilin Huang, and Hui Liu.
2022. "Loss of Heterozygosity for KrasG12D Promotes Malignant Phenotype of Pancreatic Ductal Adenocarcinoma by Activating HIF-2α-c-Myc-Regulated Glutamine Metabolism" International Journal of Molecular Sciences 23, no. 12: 6697.
https://doi.org/10.3390/ijms23126697
APA Style
Ma, Y., Ling, S., Li, Y., Hu, M., Kong, B., Huang, P., & Liu, H.
(2022). Loss of Heterozygosity for KrasG12D Promotes Malignant Phenotype of Pancreatic Ductal Adenocarcinoma by Activating HIF-2α-c-Myc-Regulated Glutamine Metabolism. International Journal of Molecular Sciences, 23(12), 6697.
https://doi.org/10.3390/ijms23126697